RxDoctor Payments Data

Stephanie Sharpe, NP

Family Health · Brockway, MINPI 1487104949

Payments from drug & device makers

$489in general payments, 2019–2025

Across 30 payments — averaging $16.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$124
  • Novo Nordisk$80
  • Otsuka America Pharmaceutical, Inc.$43
  • Boehringer Ingelheim$39
  • Exact Sciences$37
  • Mylan Specialty L.p.$35
  • plus $131 from 6 others

What the payments were for

  • Food & beverage$489100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few family health providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$33,566
Medicare patients
91
Services billed
1,661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$37,859
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$27,955
JardianceEmpagliflozin18$26,149
MounjaroTirzepatide23$23,918
TrulicityDulaglutide14$19,839
EliquisApixaban16$19,658
Tresiba Flextouch U-100Insulin Degludec12$4,370
Albuterol Sulfate HfaAlbuterol Sulfate75$2,741
Atorvastatin Calcium194$2,478
Levothyroxine Sodium146$1,758
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen113$1,534
Omeprazole110$1,454
Potassium Chloride38$1,052
Venlafaxine Hcl ErVenlafaxine Hcl29$979
Metformin Hcl73$915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$14$43,75637 claims
Novo NordiskOzempic$80$37,85918 claims
GSKTrelegy Ellipta$13$27,95544 claims
Boehringer IngelheimJardiance$39$26,14918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few family health providers in Michiganon file to place this against a meaningful peer group, so we don't.

Other family health in Brockway

Where these figures come from

Is this you, or does something look wrong? →